A Study of Pulmozyme® (Dornase Alpha) in 3- to 5-Year-Old Patients With Cystic Fibrosis

Clinical trial NCT00680316 · TERMINATED

Trial details

NCT number: NCT00680316
Sponsor: Genentech, Inc.
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Cystic Fibrosis

Start date: 2008-06-01
Primary completion: 2009-05-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.